scispace - formally typeset
K

Kate L. McElroy

Researcher at University of Texas Medical Branch

Publications -  12
Citations -  905

Kate L. McElroy is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Aedes aegypti & Yellow fever. The author has an hindex of 12, co-authored 12 publications receiving 809 citations.

Papers
More filters
Journal ArticleDOI

Impact of Wolbachia on Infection with Chikungunya and Yellow Fever Viruses in the Mosquito Vector Aedes aegypti

TL;DR: In this article, the authors examined whether the wMel strain of Wolbachia influenced CHIKV and YFV infection in Aedes aegypti and found that the extent of pathogen reduction can be influenced by the strain of bacterium.
Journal ArticleDOI

Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes.

TL;DR: O'nyong-nyong virus (ONNV) and chikungunya virus (CHIKV) are closely related alphaviruses that cause human disease in Africa and Asia and strain-variability for ONNV with respect to the ability of the virus to infect An.
Journal ArticleDOI

Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosqutioes

TL;DR: Three full-length infectious cDNA clones based on the alphavirus chikungunya (CHIKV) were developed and characterized in vitro and in vivo and have the potential for gene expression studies on this important vector species.
Journal ArticleDOI

Evaluation of the function of a type I peritrophic matrix as a physical barrier for midgut epithelium invasion by mosquito-borne pathogens in Aedes aegypti.

TL;DR: It is determined that the absence of the PM has no effect on the development of Brugia pahangi or on the dissemination of dengue virus, and the PM seems to localize proteolytic enzymes along the periphery of the blood bolus during the first 24 hours after blood feeding.
Journal ArticleDOI

Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand.

TL;DR: Considering the low level viremias anticipated in humans vaccinated with these viruses, it is predicted that the risks of infection and transmission by mosquitoes in nature is minimal.